Zimmer Biomet (ZBH) announced its RibFix Advantage Fixation System has received CE Mark certification – the first CE Mark for an intrathoracic rib fixation system. Discover the latest stocks ...

Zimmer Biomet Holdings, Inc. (ZBH) is a leading global medical device company specializing in orthopedic solutions. With a market cap of $22 billion, Zimmer Biomet operates in over 25 countries ...

Zimmer Biomet Holdings, Inc. has a twelve month low of $97.69 and a twelve month high of $133.90. The company’s fifty day moving average is $106.41 and its 200-day moving average is $106.93.

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report). The company’s shares closed yesterday at $104.03.

WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA ...

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...

1 Day ZBH 1.43% DJIA 0.11% S&P 500 0.24% Health Care/Life Sciences 1.08% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This was the stock's fourth consecutive day of gains.

“I don’t write for directors, I don’t write for producers, and I certainly don’t write for movie studios,” Hans Zimmer says in his new concert film Hans Zimmer & Friends: Diamond in the ...